Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amneal Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amneal Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Amneal Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is AMRX. The reporting company's CIK number is 1723128.
The total value of stock buying since 2005 is $406,130.
The total value of stock sales since 2005 is $856,738,918.
The total value of stock option exercises since 2005 is $491,250.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-12||Stewart Robert A (President and CEO)||Buy||17,000||11.92||202,640|
|2019-03-12||Bisaro Paul (Executive Chairman)||Buy||17,000||11.97||203,490|
|2019-03-06||Terreri Peter R||Sale||23,345||12.39||289,244|
|2019-03-06||Terreri Peter R||Option Ex||45,000||6.55||294,750|
|2019-01-15||Burr Robert L||Option Ex||30,000||6.55||196,500|
|2018-08-21||Shah Nikita (SVP, Chief HR Officer)||Sale||50,000||23.46||1,173,000|
|2018-08-21||Reasons Bryan M. (CFO)||Sale||11,698||23.65||276,657|
|2018-05-04||Aphc Holdings, Llc (10% Owner)||Sale||46,849,316||18.25||855,000,017|
Insider trading activities including stock purchases, stock sales, and option exercises of AMRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amneal Pharmaceuticals, Inc. (symbol AMRX, CIK number 1723128) see the Securities and Exchange Commission (SEC) website.